The VDGH also advocates an exemption for commercially used AI in research from the scope of the AI Act. Only by removing non-essential regulatory obstacles can innovations benefit patients in a timely manner.
The full statement can be read here.
The VDGH also advocates an exemption for commercially used AI in research from the scope of the AI Act. Only by removing non-essential regulatory obstacles can innovations benefit patients in a timely manner.
The full statement can be read here.
As a trade association, the German Diagnostics Industry Association (VDGH) represents the interests of more than 100 companies operating in Germany with a total turnover of 5.4 billion euros in 2022. They manufacture examination systems and reagents for the diagnosis of human diseases, which generate a turnover of more than 2.3 billion euros, as well as instruments, reagents, test systems and consumables for research in the life sciences, which generate a turnover of 3.1 billion euros.
We use cookies to offer you an optimal website experience. This includes cookies that are necessary for the operation of the site, as well as cookies that are only used for anonymous statistical purposes.
Data protection